海外の治験の状況「1」での検索結果
11979件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Recruiting
- Safety and Efficacy of SC0806 (Fibroblast Growth Factor 1 and a Device) in Traumatic Spinal Cord Injury Subjects
- Spinal Cord Injury
- Sweden
- 2015-06-30
Not Recruiting
- Influence of a minimized extracorporeal circulation on angiopoietin-1 and -2, and other markers of endothelial activation, a diagnostic study
- ;I25.13 - [generalization I25.1: Atherosclerotic heart disease]
- Germany
- 2015-06-25
Recruiting
- Phlebotomy and Polycystic Ovary Syndrome
- Hyperandrogenism;Metabolic Cardiovascular Syndrome
- Spain
- 2015-05-27
Not Recruiting
- Local delivery of CER-001 in advanced plaques Proof-of-concept for apoA-1 as initiator of reverse cholesterol transport
- Atherosclerosis, cardiovascular disease
- The Netherlands
- 2015-05-06
Not recruiting
- Early Treatment for Class II Division 1 Malocclusion With Twicare® and Herbst Removable Appliances
- Malocclusion, Angle Class II, Division 1
- France
- 2015-04-21
Recruiting
- Influence of Non-invasive Neurostimulation (Transcutaneous Vagus Nerve Stimulation) on 1. the Noradrenergic Release in the Brain and 2. a Neuropsychological Memory Task
- Epilepsy;Cognitive Decline;Epilepsy;Cognitive Decline;Epilepsy;Cognitive Decline;Epilepsy;Cognitive Decline
- Belgium
- 2015-03-16
Not recruiting
- Investigating the Safety and Effectiveness of Insulin Degludec in a Real World Population With Type 1 and 2 Diabetes Mellitus
- Diabetes;Diabetes Mellitus, Type 1;Diabetes Mellitus, Type 2
- Denmark, Germany, Italy, Netherlands, Spain, Sweden, Switzerland, United Kingdom
- 2015-03-12
Not recruiting
- Phase 1 Trial To Evaluate mFOLFOX6 With Selinexor In Patients With Metastatic Colorectal Cancer
- Colorectal Neoplasm
- Belgium, Germany
- 2015-03-02
Not recruiting
- A Phase 1, Single Dose Study to Evaluate the Safety and Pharmacokinetics of MEDI0382 in Healthy Volunteers
- Healthy Volunteers
- Germany
- 2015-02-26
Recruiting
- A Phase 1, Dose Finding Study of CC-90002 in Subjects With Advanced Solid and Hematologic Cancers
- Hematologic Neoplasms
- Germany, Italy, Spain, United States
- 2015-02-13
Not recruiting
- A Phase 1 Dose Escalation Study of VS-5584 Administered in Combination With VS-6063, in Subjects With Relapsed Malignant Mesothelioma
- Relapsed Malignant Mesothelioma;Relapsed Malignant Mesothelioma;Relapsed Malignant Mesothelioma;Relapsed Malignant Mesothelioma
- United Kingdom, United States
- 2015-01-30
Not recruiting
- Effects of Shifting From Twice Daily Insulin Glargine or Detemir to Once Daily Insulin Degludec in Type 1 Diabetes
- Type 1 Diabetes Mellitus
- Italy
- 2015-01-30
Not Recruiting
- Theory based patient-education, acceptance and commitment Therapy (ACT), designed for people with type 1 diabetes
- Type 1 diabetes Nutritional, Metabolic, Endocrine Diabetes mellitus
- Sweden
- 2015-01-06
Not Recruiting
- A Phase 1 and 2 study of multiple increasing doses to evaluate the ability of MEDI0382 to produce the intended result and the safety of effects of MEDI0382 in overweight and obese subjects with Type 2 Diabetes.
- Type 2 Diabetes in Overweight and Obese Patients MedDRA version: 19.0 Level: PT Classification code 10067585 Term: Type 2 diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disorders ;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
- Germany
- 2014-12-08
Authorised
- Phase 4 Study of Brentuximab Vedotin in Patients With Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma
- Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma MedDRA version: 20.0 Level: HLT Classification code 10002235 Term: Anaplastic large cell lymphomas T- and null-cell types System Organ Class: 100000004851 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Belgium, Croatia, Czech Republic, Hungary, Poland, Portugal, Romania, Spain, Turkey, United Kingdom
- 2013-04-15
Authorised
- Infliximab as first treatment instead of second line treatment in Crohns disease
- Crohn's disease;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
- Belgium, Italy, Netherlands
- 2012-07-12
Recruiting
- Personalized and Cell-based Antitumor Immunization MVX-ONCO-1 in Advanced HNSCC
- Head and Neck Squamous Cell Carcinoma;Head and Neck Squamous Cell Carcinoma;Head and Neck Squamous Cell Carcinoma
- Switzerland
- 2016-12-19
Not recruiting
- Pilot Study to Explore the Efficacy of DAPAglifozin as add-on to Closed-loop Control in Patients With Type 1 Diabetes
- Type1diabetes
- Germany
- 2016-12-06
Not recruiting
- Brown Adipose Tissue in Type 1 Diabetes
- Type1diabetes
- Sweden
- 2016-11-30
Recruiting
- First in Human Evaluation of Safety, Pharmacokinetics, and Clinical Activity of a Monoclonal Antibody Targeting Netrin 1 in Patients With Advanced/Metastatic Solid Tumors
- Advanced Solid Tumor
- France
- 2016-11-25